Shares of Oxford Biomedica plc (LON:OXB – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 248.69 ($3.22) and traded as high as GBX 355 ($4.59). Oxford Biomedica shares last traded at GBX 348.50 ($4.51), with a volume of 131,145 shares.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reaffirmed an “outperform” rating and set a GBX 740 ($9.57) target price on shares of Oxford Biomedica in a research report on Tuesday, May 21st.
View Our Latest Report on Oxford Biomedica
Oxford Biomedica Price Performance
Oxford Biomedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Articles
- Five stocks we like better than Oxford Biomedica
- Why is the Ex-Dividend Date Significant to Investors?
- Why Call Options Volume for These 2 Stocks Spiked Together
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 7/22 – 7/26
- Pros And Cons Of Monthly Dividend Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.